{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:07:34Z","timestamp":1765609654394},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T00:00:00Z","timestamp":1429747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0123974","type":"journal-article","created":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T20:25:12Z","timestamp":1429820712000},"page":"e0123974","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Rare, Serious, and Comprehensively Described Suspected Adverse Drug Reactions Reported by Surveyed Healthcare Professionals in Uganda"],"prefix":"10.1371","volume":"10","author":[{"given":"Ronald","family":"Kiguba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Karamagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Waako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen B.","family":"Ndagije","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila M.","family":"Bird","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,4,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6904-7-8","article-title":"Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study","volume":"7","author":"KJ Patel","year":"2007","journal-title":"BMC Clinical Pharmacology"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"e4439","DOI":"10.1371\/journal.pone.0004439","article-title":"Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes","volume":"4","author":"EC Davies","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"ref3","first-page":"72","article-title":"Adverse drug reactions in patients admitted on internal medicine wards in a district and regional hospital in Uganda","volume":"11","author":"WA Tumwikirize","year":"2011","journal-title":"Afr Health Sci"},{"key":"ref4","unstructured":"WHO Draft Guidelines for Adverse Event Reporting and Learning Systems, (2005)."},{"issue":"11","key":"ref5","doi-asserted-by":"crossref","first-page":"e005869","DOI":"10.1136\/bmjopen-2014-005869","article-title":"Recognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinants","volume":"4","author":"R Kiguba","year":"2014","journal-title":"BMJ Open"},{"key":"ref6","author":"Editions Pradel","year":"1994"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","article-title":"Under-reporting of adverse drug reactions: a systematic review","volume":"29","author":"L Hazell","year":"2006","journal-title":"Drug Safety"},{"key":"ref8","year":"2010"},{"key":"ref9","unstructured":"World Health Organization (WHO)\u2014Uppsala Monitoring Centre (UMC). Documentation grading\u2014how complete are the reports?: The Uppsala Monitoring Centre; 2011 [cited 2014 1 October]. Available: http:\/\/www.monitoringmedicines.org\/graphics\/26755.pdf<\/ext-link>."},{"key":"ref10","unstructured":"World Health Organization (WHO) Uppsala Monitoring Centre (UMC). Causality Assessment of Suspected Adverse Reactions [20 September 2011]. Available: http:\/\/who-umc.org\/Graphics\/24734.pdf<\/ext-link>."},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2125.2011.03944.x","article-title":"Influence of attitudes on pharmacists' intention to report serious adverse drug events to the Food and Drug Administration","volume":"72","author":"P Gavaza","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"ref12","unstructured":"World Health Organization Collaborating Centre for International Drug Monitoring (UMC). Safety Monitoring of Medicinal Products: Guidelines for Setting Up and Running a Pharmacovigilance Centre 2000 [cited 2015 15 January]. Available: http:\/\/apps.who.int\/medicinedocs\/en\/p\/printable.html<\/ext-link>."},{"key":"ref13","unstructured":"Division of AIDS. Table for Grading the Severity of Adult and Pediatric Adverse Events 2009 [cited 2014 31 July]. Available: http:\/\/rsc.tech-res.com\/Document\/safetyandpharmacovigilance\/Table_for_Grading_Severity_of_Adult_Pediatric_Adverse_Events.pdf<\/ext-link>."},{"key":"ref14","unstructured":"World Health Organization (WHO) Uppsala Monitoring Centre (UMC). Definitions [cited 2014 4 August]. Available: http:\/\/www.who.int\/medicines\/areas\/quality_safety\/safety_efficacy\/trainingcourses\/definitions.pdf<\/ext-link>."},{"key":"ref15","unstructured":"British National Formulary. London: BMJ Group and Pharmaceutical Press; 2013."},{"key":"ref16","article-title":"Stata Statistical Software: Release 12","year":"2011"},{"key":"ref17","unstructured":"Council for International Organizations of Medical Sciences (CIOMS). Benefit-Risk Balance for Marketed Drugs: Evaluating Safety Signals. Geneva1998 [cited 2014 4 August]. Available: http:\/\/www.cioms.ch\/publications\/g4-benefit-risk.pdf<\/ext-link>."},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/0091270005283285","article-title":"Challenges and opportunities for pharmacoepidemiology in drug-therapy decision making","volume":"46","author":"M Etminan","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1475-2875-5-50","article-title":"Pharmacovigilance of antimalarial treatment in Africa: is it possible?","volume":"5","author":"AO Talisuna","year":"2006","journal-title":"Malar J"},{"issue":"1","key":"ref20","first-page":"144","article-title":"Gluteal Fibrosis. A report of 28 cases from Kumi Hospital, Uganda","volume":"12","author":"J Ekure","year":"2006","journal-title":"East and Central African Journal of Surgery"},{"key":"ref21","year":"2012"},{"key":"ref22","unstructured":"Actavis UK Ltd. Summary of Product Characteristics\u2014Quinine Sulphate Tablets BP 300mg Whiddon Valley, Barnstaple, Devon, EX32 8NS, UK: Datapharm; 2013 [updated 22 April; cited 2014 19 September]. Available: http:\/\/www.medicines.org.uk\/emc\/medicine\/24467<\/ext-link>."},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4103\/0022-3859.81865","article-title":"Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study","volume":"57","author":"M Barvaliya","year":"2011","journal-title":"Journal of Postgraduate Medicine"},{"issue":"1\u20132","key":"ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000321728","article-title":"Hemoptysis under diclofenac and antiplatelet doses of aspirin","volume":"87","author":"EC Yiannakopoulou","year":"2011","journal-title":"Pharmacology"},{"issue":"1\u20132","key":"ref25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000336059","article-title":"Hemoptysis and Pulmonary Edema in a Scuba Diver Using Diclofenac","volume":"89","author":"D Van Renterghem","year":"2012","journal-title":"Pharmacology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0123974","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T19:42:43Z","timestamp":1540237363000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0123974"}},"subtitle":[],"editor":[{"given":"Antje","family":"Timmer","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,23]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0123974","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,23]]}}}